カテゴリ： Allied Market Research, 世界, 医療/バイオ

梅毒イムノアッセイ診断のグローバル市場（2021〜2031）：アナライザー、キット・試薬

■ 英語タイトル：Syphilis Immunoassay Diagnostics Market By Product Type (Analyzers, Kits and reagents), By Technology (CLIA, ELISA), By End User (Blood Banks, Diagnostic Labs, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23FB213）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23FB213
■ 発行日：2022年10月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：247
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[梅毒イムノアッセイ診断のグローバル市場（2021〜2031）：アナライザー、キット・試薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に315.5百万ドルであった世界の梅毒イムノアッセイ診断市場規模が、2031年までに446.0百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）3.5%で成長すると予測しています。本レポートは、梅毒イムノアッセイ診断の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（アナライザー、キット・試薬）分析、技術別（CLIA、ELISA）分析、エンドユーザー別（血液バンク、診断研究室、病院）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、BioRad Laboratories Inc、Danaher Corporation、BECTON DICKINSON & COMPANY、, F. Hoffmann-La Roche AG、Siemens Healthineers AG、Diasorin S.P.Aなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の梅毒イムノアッセイ診断市場規模：製品別
- アナライザーの市場規模
- キット・試薬の市場規模
・世界の梅毒イムノアッセイ診断市場規模：技術別
- CLIAにおける市場規模
- ELISAにおける市場規模
・世界の梅毒イムノアッセイ診断市場規模：エンドユーザー別
- 血液バンクにおける市場規模
- 診断研究室における市場規模
- 病院における市場規模
・世界の梅毒イムノアッセイ診断市場規模：地域別
- 北米の梅毒イムノアッセイ診断市場規模
- ヨーロッパの梅毒イムノアッセイ診断市場規模
- アジア太平洋の梅毒イムノアッセイ診断市場規模
- 中南米・中東・アフリカの梅毒イムノアッセイ診断市場規模
・企業状況
・企業情報

梅毒イムノアッセイ診断の世界市場は、2021年には3億1,550万ドルと評価され、2022年から2031年までの年平均成長率は3.5%を記録し、2031年には4億4,600万ドルに達すると予測されています。

梅毒は、性的接触によって感染する慢性の細菌感染症です。梅毒はTreponema pallidumとして知られる細菌の一種によって引き起こされます。梅毒の4つの段階には、一次、二次、潜伏、三次があります。梅毒の初発段階は、細菌に感染してから約3～4週間後に起こります。梅毒の第2期には、皮膚の発疹やのどの痛みが生じます。一次、二次と症状が消失し、梅毒の潜伏期になると目立った症状は出なくなります。第三期になると、失明、難聴、精神状態を引き起こすことがあります。この病気の診断には、梅毒のスクリーニング検査のために髄液を採取することが含まれます。さらに、梅毒の血液検査では、梅毒菌（Treponema pallidum）に対する抗体を調べます。梅毒検査には、T pallidum微小凝集測定法、T pallidum粒子凝集測定法、T pallidum血球凝集測定法、蛍光トレポネーマ抗体吸収（FTA-ABS）検査法、トレポネーマ抗体を検出する化学発光免疫測定法、酵素免疫測定法などがあります。

梅毒イムノアッセイ診断市場の成長は、性感染症や、ヘロイン、コカイン、覚醒剤、大麻、ベンゾジアゼピン、アルコールなど多数の薬物の影響下での性行為の割合の増加といった社会経済的要因の上昇が原動力となっています。さらに、致死的梅毒感染率の増加、検査施設の急増、検査における技術の普及、その場での検査が可能になったことも、市場の成長に貢献しています。例えば、世界保健機関（WHO）のデータによると、2020年にはクラミジア（1億2900万人）、淋病（8200万人）、梅毒（710万人）、トリコモナス（1億5600万人）など4つの性病のうち1つに新たに感染する人が3億7400万人いると推定されています。しかし、新興国では個人の知識不足がこの市場の成長を妨げると予想されます。逆に、未開拓の新興経済国での高い成長の可能性は、市場に有利な機会をもたらすと期待されています。

梅毒イムノアッセイ診断の世界市場は、製品タイプ、技術、エンドユーザー、地域によって区分されます。製品タイプ別では、市場は分析装置とキット＆試薬に分けられます。技術別では、市場はCLIAとELISAに二分されます。エンドユーザー別では、血液銀行、診断ラボ、病院に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）に市場を分けて分析しています。

〈ステークホルダーにとっての主なメリット〉
・2021年から2031年までの梅毒イムノアッセイ診断市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、梅毒イムノアッセイ診断市場の有力な市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
・梅毒イムノアッセイ診断市場のセグメンテーションの詳細な分析により、市場機会を決定します。
・各地域の主要国について、世界市場に対する収益貢献度をマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・梅毒イムノアッセイ診断の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品タイプ別
分析装置
キット・試薬

技術別
CLIA
ELISA

エンドユーザー別
血液銀行
診断ラボ
病院

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
BioRad Laboratories Inc
Danaher Corporation
BECTON DICKINSON & COMPANY
F. Hoffmann-La Roche AG
Siemens Healthineers AG
Diasorin S.P.A
Abbott Laboratories
Fujirebio
BioMerieux SA
Shenzhen New Industries Biomedical Engineering Co. Ltd

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Analyzers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Kits and reagents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 CLIA
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 ELISA
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Blood Banks
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Diagnostic Labs
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Hospitals
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Technology
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Technology
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Technology
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Technology
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Technology
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Technology
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Technology
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Technology
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Technology
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Technology
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Technology
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Technology
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Technology
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Technology
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Technology
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Technology
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Technology
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Technology
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Technology
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 BioRad Laboratories Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Danaher Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 BECTON DICKINSON & COMPANY
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 , F. Hoffmann-La Roche AG
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Siemens Healthineers AG
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Diasorin S.P.A
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Abbott Laboratories
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Fujirebio
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 , BioMerieux SA
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Shenzhen New Industries Biomedical Engineering Co. Ltd
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ANALYZERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ANALYZERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR KITS AND REAGENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR KITS AND REAGENTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 7. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR CLIA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR CLIA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ELISA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ELISA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 12. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR BLOOD BANKS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR BLOOD BANKS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 14. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 32. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 51. REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 58. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 66. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 67. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 69. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 70. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 73. REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 76. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 80. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 92.BIORAD LABORATORIES INC: COMPANY SNAPSHOT
TABLE 93.BIORAD LABORATORIES INC: OPERATING SEGMENTS
TABLE 94.BIORAD LABORATORIES INC: PRODUCT PORTFOLIO
TABLE 95.BIORAD LABORATORIES INC: NET SALES
TABLE 96.BIORAD LABORATORIES INC: KEY STRATERGIES
TABLE 97.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 98.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 99.DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 100.DANAHER CORPORATION: NET SALES
TABLE 101.DANAHER CORPORATION: KEY STRATERGIES
TABLE 102.BECTON DICKINSON & COMPANY: COMPANY SNAPSHOT
TABLE 103.BECTON DICKINSON & COMPANY: OPERATING SEGMENTS
TABLE 104.BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
TABLE 105.BECTON DICKINSON & COMPANY: NET SALES
TABLE 106.BECTON DICKINSON & COMPANY: KEY STRATERGIES
TABLE 107., F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
TABLE 108., F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
TABLE 109., F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
TABLE 110., F. HOFFMANN-LA ROCHE AG: NET SALES
TABLE 111., F. HOFFMANN-LA ROCHE AG: KEY STRATERGIES
TABLE 112.SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
TABLE 113.SIEMENS HEALTHINEERS AG: OPERATING SEGMENTS
TABLE 114.SIEMENS HEALTHINEERS AG: PRODUCT PORTFOLIO
TABLE 115.SIEMENS HEALTHINEERS AG: NET SALES
TABLE 116.SIEMENS HEALTHINEERS AG: KEY STRATERGIES
TABLE 117.DIASORIN S.P.A: COMPANY SNAPSHOT
TABLE 118.DIASORIN S.P.A: OPERATING SEGMENTS
TABLE 119.DIASORIN S.P.A: PRODUCT PORTFOLIO
TABLE 120.DIASORIN S.P.A: NET SALES
TABLE 121.DIASORIN S.P.A: KEY STRATERGIES
TABLE 122.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 123.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 124.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 125.ABBOTT LABORATORIES: NET SALES
TABLE 126.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 127.FUJIREBIO: COMPANY SNAPSHOT
TABLE 128.FUJIREBIO: OPERATING SEGMENTS
TABLE 129.FUJIREBIO: PRODUCT PORTFOLIO
TABLE 130.FUJIREBIO: NET SALES
TABLE 131.FUJIREBIO: KEY STRATERGIES
TABLE 132., BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 133., BIOMERIEUX SA: OPERATING SEGMENTS
TABLE 134., BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 135., BIOMERIEUX SA: NET SALES
TABLE 136., BIOMERIEUX SA: KEY STRATERGIES
TABLE 137.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: COMPANY SNAPSHOT
TABLE 138.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: OPERATING SEGMENTS
TABLE 139.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: PRODUCT PORTFOLIO
TABLE 140.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: NET SALES
TABLE 141.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ビデオ喉頭鏡のグローバル市場（2021〜2031）：固定型、汎用型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23FB213 )"梅毒イムノアッセイ診断のグローバル市場（2021〜2031）：アナライザー、キット・試薬" (英文：Syphilis Immunoassay Diagnostics Market By Product Type (Analyzers, Kits and reagents), By Technology (CLIA, ELISA), By End User (Blood Banks, Diagnostic Labs, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。